Stock Events

Stock Events

Search...

Arrowhead Pharmaceuticals (A2RR34.SA) Q4 2023 Earnings

29NovConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-9.42

-5.52

-1.63

2.27

Details

Expected EPS

-2.991562

Actual EPS

-9.416064

Surprise EPS

-6.42

Surprise Percent

+214.75%

Description

Arrowhead Pharmaceuticals (A2RR34.SA) has reported earnings of -9.416064 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.